-
1Academic Journal
المؤلفون: Luis Teixeira, Christelle Levy, David Coeffic, Rim Ghorbal, Julien Dupin, Nazario Esposito, Olfa Derbel
المصدر: BMC Digital Health, Vol 3, Iss 1, Pp 1-12 (2025)
مصطلحات موضوعية: Breast cancer, Medical device, Feasibility, Symptom management, Treatment management, Patient Reported Outcome, Computer applications to medicine. Medical informatics, R858-859.7
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2731-684X
-
2Academic Journal
المؤلفون: Olivier Tredan, Marie Laurent, Melina Gilberg, Rim Ghorbal, Alexandre Vainchtock, Joannie Lortet-Tieulent, Martin Prodel, Julien Dupin
المصدر: Cancer Informatics, Vol 21 (2022)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1176-9351
-
3Academic Journal
المؤلفون: Bruno Coudert, Jean-Yves Pierga, Marie-Ange Mouret-Reynier, Kaldoun Kerrou, Jean-Marc Ferrero, Thierry Petit, Fanny Le Du, Pierre-François Dupré, Thomas Bachelot, Philippe Gabelle, Marie-Pierre Chauvet, David Coeffic, Catherine Barbe, Jean-Briac Prevost, Gilles Paintaud, Gilles Thibault, Abdennour Ferhat, Julien Dupin, Alina Berriolo-Riedinger, Laurent Arnould
المصدر: EClinicalMedicine, Vol 28, Iss , Pp 100566- (2020)
مصطلحات موضوعية: Her-2 positive breast cancer, Bevacizumab, Neoadjuvant, Positron emission tomography, Early pet assessment, Δsuvmax, Medicine (General), R5-920
وصف الملف: electronic resource
-
4
المؤلفون: Jean-Julien Dupin, Amandine Pascal, Cécile Godé
المساهمون: Laboratoire d'Economie et de Sociologie du Travail (LEST), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche sur le Transport et la Logistique (CRET-LOG), Aix Marseille Université (AMU)
المصدر: Management & Data Science
Management & Data Science, 2022, 6 (2), ⟨10.36863/mds.a.20378⟩مصطلحات موضوعية: Digital transformation, [SHS.GESTION]Humanities and Social Sciences/Business administration, Digital resilience
-
5
المؤلفون: Jean-Yves Pierga, Alina Berriolo-Riedinger, Thierry Petit, Laurent Arnould, David Coeffic, Abdennour Ferhat, Gilles Paintaud, Jean-Briac Prevost, Pierre-Francois Dupre, Fanny Le Du, Thomas Bachelot, Marie-Pierre Chauvet, Jean-Marc Ferrero, Gilles Thibault, Kaldoun Kerrou, Philippe Gabelle, Catherine Barbe, Julien Dupin, Bruno Coudert, Marie-Ange Mouret-Reynier
المساهمون: Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Institut Curie [Paris], Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Paul Strauss, CRLCC Paul Strauss, Centre Eugène Marquis (CRLCC), Hôpital Morvan - CHRU de Brest (CHU - BREST ), Centre Léon Bérard [Lyon], Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Roche France, Département d'information médicale [Centre Georges-François Leclerc] (DIM), UNICANCER-UNICANCER, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Lille-UNICANCER
المصدر: EClinicalMedicine
EClinicalMedicine, Elsevier, 2020, 28, pp.100566. ⟨10.1016/j.eclinm.2020.100566⟩
EClinicalMedicine, Vol 28, Iss, Pp 100566-(2020)
EClinicalMedicine, 2020, 28, pp.100566. ⟨10.1016/j.eclinm.2020.100566⟩مصطلحات موضوعية: Oncology, medicine.medical_specialty, Positron emission tomography, Early pet assessment, Bevacizumab, medicine.medical_treatment, [SDV]Life Sciences [q-bio], 01 natural sciences, Group B, 03 medical and health sciences, Her-2 positive breast cancer, 0302 clinical medicine, Breast cancer, Trastuzumab, Internal medicine, medicine, Adjuvant therapy, 030212 general & internal medicine, 0101 mathematics, Adverse effect, Long-term follow-up, Neoadjuvant therapy, lcsh:R5-920, business.industry, 010102 general mathematics, General Medicine, medicine.disease, 3. Good health, Docetaxel, pathological complete response, Δsuvmax, Neoadjuvant, lcsh:Medicine (General), business, Research Paper, medicine.drug
-
6
المؤلفون: Alexandre Vainchtock, Julien Dupin, M. Laurent, V. Machuron, R. Ghorbal, B Tehard, M. Gilberg, M. Prodel
المصدر: Value in Health. 23:S471-S472
مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Medicine, Retrospective cohort study, business, Early breast cancer
-
7
المؤلفون: Olivier Tredan, R. Ghorbal, D. Perol, M. Gilberg, Julien Dupin, A. Livartowski, Paul-Henri Cottu, C. Maillard
المصدر: Value in Health. 23:S456
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Trastuzumab, Neoadjuvant treatment, business.industry, Health Policy, Internal medicine, Public Health, Environmental and Occupational Health, medicine, Retrospective cohort study, business, medicine.drug, Early breast cancer
-
8
المؤلفون: R. Ghorbal, C. Maillard, D. Pérol, Paul-Henri Cottu, O. Trédan, M. Gilberg, A. Livartoswki, Julien Dupin
المصدر: Revue d'Épidémiologie et de Santé Publique. 68:S62
مصطلحات موضوعية: Epidemiology, Public Health, Environmental and Occupational Health
-
9
المؤلفون: Olfa Derbel, Julien Dupin, Luis Augusto Teixeira, Christelle Levy, David Coeffic, Nazario Esposito, Rim Ghorbal
المصدر: Journal of Clinical Oncology. 38:e14107-e14107
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Medical device, Breast cancer, Oncology, Multicenter study, business.industry, medicine, In patient, Symptom monitoring, medicine.disease, Intensive care medicine, business
-
10
المؤلفون: Pierre-Francois Dupre, Marie-Pierre Chauvet, Jean Marc Ferrero, David Coeffic, Jean-Briac Prevost, Thomas Bachelot, Thierry Petit, Alina Berriolo-Riedinger, Catherine Barbe, Julien Dupin, Gilles Paintaud, Kaldoun Kerrou, Philippe Gabelle, Laurent Arnould, Jean-Yves Pierga, Fanny Le Du, Marie-Ange Mouret-Reynier, Bruno Coudert, Abdennour Ferhat
المصدر: SSRN Electronic Journal.
مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, business.industry, medicine.medical_treatment, medicine.disease, Breast cancer, Docetaxel, Trastuzumab, Internal medicine, medicine, Hormonal therapy, Cumulative incidence, business, Adverse effect, Neoadjuvant therapy, medicine.drug
-
11
المؤلفون: Yara Rocha, Y. Ghazi, Sabine Balouet, D Pau, Roman Rouzier, Julien Dupin, Florence Joly, V. Menguy, Christine Laurent
المصدر: Contemporary clinical trials. 65
مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, Paclitaxel, Carboplatin, 03 medical and health sciences, 0302 clinical medicine, Postoperative Complications, Multidisciplinary approach, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Intensive care medicine, Case report form, Ovarian Neoplasms, business.industry, Stopping rule, Bayes Theorem, General Medicine, medicine.disease, Debulking, Discontinuation, Clinical trial, Chemotherapy, Adjuvant, Research Design, 030220 oncology & carcinogenesis, Female, business, Ovarian cancer, medicine.drug
-
12
المؤلفون: Julien Dupin, Anne Floquet, Roman Rouzier, A. Lesoin, Frédéric Selle, Sandrine Martin-Francoise, Raffaèle Fauvet, Sebastien Gouy, Elisabeth Chereau, Paul Cottu, Pierre-Emmanuel Colombo, Eric Lambaudie, Sarah Zohar, Fabrice Lecuru, Christophe Pomel, Florence Joly, Virginie Fourchotte, Philippe Follana, Y. Ghazi, Elsa Kalbacher
المساهمون: CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Gustave Roussy (IGR), Alliance Pour la Recherche En Cancérologie [CHU Tenon] (APREC), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Beninois pour l'Environnement et le développement économique et Social (CEBEDES), Service de Chirurgie Oncologique, Institut Curie [Paris], Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de Recherche Saint-Antoine (UMRS893), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de signalisation, biologie du développement et cancer (ISBDC), Centre National de la Recherche Scientifique (CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre de Recherche des Cordeliers (CRC), Université Pierre et Marie Curie - Paris 6 (UPMC)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de recherche translationnelle, GenoSciencePharma, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), Université Pierre et Marie Curie - Paris 6 (UPMC)-École Pratique des Hautes Études (EPHE), Département de Recherche Translationnelle, CHU Tenon [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Tenon [APHP], Institut Curie, Imagerie Moléculaire et Stratégies Théranostiques - Clermont Auvergne (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Centre Jean Perrin, CRLCC Jean Perrin, Centre de Recherche Saint-Antoine (CR Saint-Antoine), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Université Nice Sophia Antipolis (... - 2019) (UNS), Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-Centre National de la Recherche Scientifique (CNRS), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Université Paris Diderot - Paris 7 (UPD7)-École pratique des hautes études (EPHE)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 70, pp.133-142. ⟨10.1016/j.ejca.2016.09.036⟩
European Journal of Cancer, 2017, 70, pp.133-142. ⟨10.1016/j.ejca.2016.09.036⟩مصطلحات موضوعية: Adult, Cancer Research, medicine.medical_specialty, Bevacizumab, Paclitaxel, medicine.medical_treatment, Optimal Debulking, [SDV]Life Sciences [q-bio], education, Phases of clinical research, Angiogenesis Inhibitors, Adenocarcinoma, Interval debulking surgery, Neoadjuvant chemotherapy, Carboplatin, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Stage IIIC, 030212 general & internal medicine, Adverse effect, Neoadjuvant therapy, Peritoneal Neoplasms, Aged, Ovarian Neoplasms, business.industry, Cytoreduction Surgical Procedures, Middle Aged, Debulking, Neoadjuvant Therapy, female genital diseases and pregnancy complications, 3. Good health, Surgery, Oncology, 030220 oncology & carcinogenesis, Concomitant, Female, business, medicine.drug
-
13
المؤلفون: F. Joly Lobbedez, Anne Floquet, Patricia Pautier, Frédéric Selle, Elsa Kalbacher, Jacques Medioni, T. de La Motte Rouge, Julien Dupin, Magali Provansal, Roman Rouzier, PH Cottu, Philippe Follana, A. Lesoin, Michel Fabbro, F-C Bidard, R-M. Ferri, Coraline Dubot
المصدر: Annals of Oncology. 28:v336-v337
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Ovarian carcinoma, Internal medicine, medicine, CA 15-3, Tumor cells, Hematology, business
-
14
المؤلفون: Marisol Urbieta, Eric Leblanc, Paul Cottu, Elisabeth Chereau, Christophe Pomel, Romain Rouzier, Sebastien Gouy, Sarah Zohar, Julien Dupin, Leila Kockler, Sabine Balouet, Florence Joly, Eric Lambaudie, Rose-Marie Ferri, Anne Floquet, Frédéric Selle
المصدر: Journal of Clinical Oncology. 35:5538-5538
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Advanced ovarian cancer, 030219 obstetrics & reproductive medicine, Bevacizumab, business.industry, medicine.medical_treatment, Complete resection, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Paclitaxel, 030220 oncology & carcinogenesis, Internal medicine, Medicine, In patient, Long term safety, business, Adjuvant, medicine.drug
-
15
المؤلفون: Florence Joly, Eric Lambaudie, Pierre-Emmanuel Colombo, Frédéric Selle, Roman Rouzier, S. Martin-Francoise, Frederic Guyon, Raffaèle Fauvet, Elisabeth Chereau, Fabrice Lecuru, Sarah Zohar, Sebastien Gouy, Virginie Fourchotte, A. Lesoin, Paul-Henri Cottu, Julien Dupin, Y. Ghazi, Philippe Follana, Elsa Kalbacher, Christophe Pomel
المصدر: Annals of Oncology. 27:vi297
مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, business.industry, medicine.medical_treatment, Hematology, Debulking, Complete resection, Surgery, Oncology, medicine, Interval (graph theory), business, Neoadjuvant therapy, medicine.drug
-
16
-
17
-
18
-
19
-
20